Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Wegovy Demand Busts Through Novo Nordisk’s Expanded Capacity

May 04 2023

• By Jessica Merrill

fist banging through a wall — Wegovy demand continues to outpace supply • Source: Shutterstock

Related Content

Wegovy CVOT Data Could Pave The Way For Broad Reimbursement, CEO Says

Mar 29 2023

Five Clinical Trial Hits Of 2022

Jan 23 2023

Lilly’s Mounjaro Shows Strong Sales And Data As Firm Eyes Obesity Market

Apr 27 2023

Lilly Offloads Baqsimi To Amphastar While Investing In Mounjaro Head-To-Head Trial

Apr 24 2023

Novo Preempts Earnings Reveal With Preview Of Wegovy-Driven Growth

Apr 13 2023

Lilly And Novo Nordisk Shape Up For Obesity Treatment Battle Of The Heavyweights

Apr 06 2023

Novo’s Obesity Franchise On Track For YE22 But Diabetes Pipeline Steals Show During Q3

Nov 02 2022

Related Companies

Novo Nordisk A/S

Eli Lilly and Company

Additional Topics

Sales & Earnings Launches Supply Chain Commercial Business Strategies Metabolic Disorders

More from Alimentary/Metabolic

More from Therapeutic Category

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window